Two New Ebola Deaths Recorded in DRC Outbreak

The recent cases come just as Democratic Republic of Congo was set to declare the outbreak’s end.

Written byAmy Schleunes
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, MOHAMMED HANEEFA NIZAMUDEEN

A new case of Ebola has been confirmed in Beni, a city in the North Kivu province of Democratic Republic of Congo, the World Health Organization announced on Friday (April 10). The 26-year-old man died from the infection in the first Ebola case to have emerged after 52 days without a diagnosis, reports STAT. DRC was expected to declare the end of the outbreak today, but the new diagnosis puts that declaration on hold.

“I am so sad,” WHO epidemiologist Marie-Roseline Darnycka Bélizaire tells Nature. “I expected a sporadic case earlier, but not two days before the end.”

Tedros Adhanom Ghebreyesus, the director-general of the WHO, stated during a briefing that the DRC government would not be able to “declare an end to the outbreak on Monday as was hoped,” but that “WHO and all partners remain on the ground and committed as ever ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies